feed,title,long_url,short_url
SeekingAlpha,Beam Therapeutics: Early Stage Gene Editing Company With Cutting Edge Technology,https://seekingalpha.com/article/4393176,
SeekingAlpha,IPO Update: PubMatic Targets $100 Million IPO,https://seekingalpha.com/article/4393175,
